<qa>  What is the primary objective of this trial?The primary objective of this trial is to demonstrate that infants receiving an infant formula in which 40 or 50 of the palmitic acid is in the sn-2 position have, during the first 4 months of life, stools that are softer than those of infants receiving a control formula. 